{"id":4951,"date":"2026-02-23T07:16:41","date_gmt":"2026-02-23T06:16:41","guid":{"rendered":"https:\/\/hepc.ch\/es-besteht-hoffnung-dass-chronische-hepatitis-b-in-ein-paar-jahren-geheilt-werden-kann\/"},"modified":"2026-02-24T06:45:09","modified_gmt":"2026-02-24T05:45:09","slug":"es-besteht-hoffnung-dass-chronische-hepatitis-b-in-ein-paar-jahren-geheilt-werden-kann","status":"publish","type":"post","link":"https:\/\/hepc.ch\/en\/es-besteht-hoffnung-dass-chronische-hepatitis-b-in-ein-paar-jahren-geheilt-werden-kann\/","title":{"rendered":"There is hope that chronic hepatitis B can be cured in a few years"},"content":{"rendered":"<p>The EU-funded TherVacB project is launching a study involving 81 patients to test its experimental therapeutic vaccine against chronic hepatitis B. Unlike prophylactic vaccination, which prevents infection with the hepatitis B virus, this vaccine is only administered after the disease has broken out.<\/p>\n<p>The human immune system can successfully eliminate acute hepatitis B virus (HBV) infection in about 90% of adults. The key to this is an effective, virus-specific response from B and T cells, which leads to virus control and ultimately to a cure. In chronic HBV infection, however, these B and T cell responses are barely detectable and impaired in their function.<\/p>\n<p>TherVacB aims to break through this HBV-specific immune tolerance. With the help of therapeutic vaccination, antiviral B and T cell responses are to be restored in order to achieve a permanent cure for HBV.<\/p>\n<p><a href=\"https:\/\/www.thervacb.eu\/the-project\/\" title=\"TherVacB\" rel=\"noopener nofollow \" target=\"_blank\">TherVacB website<\/a><br \/>\n<a href=\"https:\/\/cordis.europa.eu\/article\/id\/461120-towards-a-cure-for-hepatitis-b\" title=\"Towards A Cure For Hepatitis B\" rel=\"noopener nofollow \" target=\"_blank\">CORDIS Towards A Cure For Hepatitis B<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The EU-funded TherVacB project is launching a study involving 81 patients to test its experimental therapeutic vaccine against chronic hepatitis B. Unlike prophylactic vaccination, which prevents infection with the hepatitis B virus, this vaccine is only administered after the disease has broken out. The human immune system can successfully eliminate acute hepatitis B virus (HBV)\u2026 <span class=\"read-more\"><a href=\"https:\/\/hepc.ch\/en\/es-besteht-hoffnung-dass-chronische-hepatitis-b-in-ein-paar-jahren-geheilt-werden-kann\/\">Read More &raquo;<\/a><\/span><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[],"class_list":["post-4951","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/hepc.ch\/en\/wp-json\/wp\/v2\/posts\/4951","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hepc.ch\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hepc.ch\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hepc.ch\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/hepc.ch\/en\/wp-json\/wp\/v2\/comments?post=4951"}],"version-history":[{"count":3,"href":"https:\/\/hepc.ch\/en\/wp-json\/wp\/v2\/posts\/4951\/revisions"}],"predecessor-version":[{"id":4964,"href":"https:\/\/hepc.ch\/en\/wp-json\/wp\/v2\/posts\/4951\/revisions\/4964"}],"wp:attachment":[{"href":"https:\/\/hepc.ch\/en\/wp-json\/wp\/v2\/media?parent=4951"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hepc.ch\/en\/wp-json\/wp\/v2\/categories?post=4951"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hepc.ch\/en\/wp-json\/wp\/v2\/tags?post=4951"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}